Intuitive Surgical (NASDAQ:ISRG) Releases Earnings Results, Beats Expectations By $0.10 EPS

Intuitive Surgical (NASDAQ:ISRG) posted its quarterly earnings data on Thursday. The medical equipment provider reported $1.50 earnings per share for the quarter, topping analysts’ consensus estimates of $1.40 by $0.10, Briefing.com reports. Intuitive Surgical had a return on equity of 13.11% and a net margin of 25.24%. The business had revenue of $1.89 billion for the quarter, compared to analyst estimates of $1.87 billion. During the same quarter in the prior year, the company earned $1.00 earnings per share. The company’s revenue was up 11.5% on a year-over-year basis.

Intuitive Surgical Stock Down 0.4 %

Shares of NASDAQ:ISRG opened at $372.63 on Friday. The company has a 50-day moving average price of $387.27 and a 200 day moving average price of $342.60. Intuitive Surgical has a 52 week low of $254.85 and a 52 week high of $403.76. The company has a market cap of $132.08 billion, a P/E ratio of 74.08, a PEG ratio of 5.81 and a beta of 1.36.

Insider Activity

In other news, EVP Robert Desantis sold 20,296 shares of Intuitive Surgical stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $393.80, for a total transaction of $7,992,564.80. Following the completion of the sale, the executive vice president now directly owns 5,507 shares in the company, valued at approximately $2,168,656.60. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other Intuitive Surgical news, EVP Myriam Curet sold 4,318 shares of Intuitive Surgical stock in a transaction that occurred on Friday, January 26th. The shares were sold at an average price of $370.15, for a total value of $1,598,307.70. Following the completion of the sale, the executive vice president now directly owns 189 shares of the company’s stock, valued at approximately $69,958.35. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Robert Desantis sold 20,296 shares of Intuitive Surgical stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $393.80, for a total transaction of $7,992,564.80. Following the completion of the sale, the executive vice president now directly owns 5,507 shares of the company’s stock, valued at $2,168,656.60. The disclosure for this sale can be found here. In the last three months, insiders sold 248,418 shares of company stock worth $95,927,097. Company insiders own 0.90% of the company’s stock.

Hedge Funds Weigh In On Intuitive Surgical

A number of hedge funds have recently made changes to their positions in the stock. FIL Ltd boosted its holdings in shares of Intuitive Surgical by 207.3% in the 4th quarter. FIL Ltd now owns 108,892 shares of the medical equipment provider’s stock valued at $36,736,000 after purchasing an additional 73,458 shares during the last quarter. Burford Brothers Inc. acquired a new position in shares of Intuitive Surgical during the 4th quarter valued at $228,000. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main lifted its holdings in shares of Intuitive Surgical by 165.6% during the 4th quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 6,294 shares of the medical equipment provider’s stock valued at $2,124,000 after acquiring an additional 3,924 shares in the last quarter. Hobbs Group Advisors LLC acquired a new position in shares of Intuitive Surgical during the 4th quarter valued at $335,000. Finally, SageView Advisory Group LLC lifted its holdings in shares of Intuitive Surgical by 619.1% during the 4th quarter. SageView Advisory Group LLC now owns 4,926 shares of the medical equipment provider’s stock valued at $1,662,000 after acquiring an additional 4,241 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have recently weighed in on ISRG shares. Royal Bank of Canada upped their price objective on Intuitive Surgical from $400.00 to $432.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 24th. StockNews.com lowered Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Thursday, February 29th. Barclays increased their target price on Intuitive Surgical from $385.00 to $430.00 and gave the company an “overweight” rating in a report on Thursday, January 25th. Wells Fargo & Company raised their price objective on Intuitive Surgical from $363.00 to $416.00 and gave the stock an “overweight” rating in a report on Friday, January 19th. Finally, Raymond James raised their price objective on Intuitive Surgical from $372.00 to $435.00 and gave the stock an “outperform” rating in a report on Thursday, January 25th. Five research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $375.70.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.